Dr. Reddy's Laboratories Limited (RDY) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Dr. Reddy's Laboratories Limited (RDY) closed at USD 12.75 on 2026-10-14, a change of -12.1 % over the past year, with a market capitalization of USD 10.75B.

Dr. Reddy's Laboratories Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Dr. Reddy's Laboratories Limited key figures

Previous close

USD 12.75 (2026-10-14)

1-year change

-12.1 %

Market cap

USD 10.75B

Enterprise value

USD 58.18B

P/E ratio (trailing)

29.32

P/E ratio (forward)

20.11

EPS (trailing)

0.44

EPS (forward)

0.64

PEG ratio

1.70

Price to book

16.17

Revenue growth

-5.6 %

Earnings growth

-68.7 %

Dividend per share (trailing)

8.00

Short ratio

8.96

Employees

27,527

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Dr. Reddy's Laboratories Limited and compare it with other stocks.